
MindImmune Appoints Vice President, Preclinical Development
MindImmune Therapeutics has appointed Thomas Prod’homme, Ph.D., as Vice President, Preclinical Development. Dr. Prod’homme will lead cross-disciplinary preclinical strategy for MindImmune’s pipeline, including its monoclonal antibody candidate MITI-101, …